Latest filing published 16 Aug 2021 for Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.), €20k.
David M. Hall discloses dealings in Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) to SEDI. We count 4 filings; the first trade dates from 15 March 2019 and the latest from 12 August 2021.
Every open-market trade on record is a sale: 1 sale worth €24k. The rest of the record consists of 1 option exercise. In 2021 alone, the filings show no purchases and 1 sale.
On 16 August 2021 came the latest disclosure, an option exercise for €20k in Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.). Typically, a trade is published a median of 4 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations